A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast CancerHariprasad Thangavel, Meghana V. Trivedi, Carmine De Angelis et al.|Journal of Clinical Medicine|2019Cited by 43
NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancerRaksha R. Bhat, Meghana V. Trivedi, Hariprasad Thangavel et al.|Scientific Reports|2022Cited by 27
A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2‐positive breast cancerNoor Mazin Abdulkareem, Meghana V. Trivedi, Martin J. Shea et al.|The FASEB Journal|2021Cited by 25
Screening of GPCR drugs for repurposing in breast cancerNoor Mazin Abdulkareem, Meghana V. Trivedi, Raksha R. Bhat et al.|Frontiers in Pharmacology|2022Cited by 19
Abstract 5148: ADGRG1 promotes tumorigenesis, invasion/migration, and cell-cell adhesion in triple-negative breast cancer cellsRaksha R. Bhat, Meghana V. Trivedi, Noor Mazin Abdulkareem et al.|Cancer Research|2020Cited by 14